Figure 4.
Figure 4. p60src kinase activity in NIH-EGFR/ALK cells following EGF stimulation. Quiescent NIH-EGFR/ALK cells were either mock-treated or treated with 100 ng/mL EGF for the indicated time at 37°C. Cell lysates were immunoprecipitated with an anti-p60src antibody. (A) An aliquot from each immunoprecipitate was directly analyzed by immunoblotting to evaluate p60src content. (B) The remainder of each immunoprecipitate was subjected to in vitro kinase assay in the presence of [γ-32P] ATP and acid-denaturated enolase. Samples were then analyzed by SDS-PAGE and autoradiography. (C) The 32P content of bands corresponding to enolase shown in panel B was quantified by densitometric scanning of the autoradiograms and results are expressed as percent of control (signal obtained from medium-treated cells).

p60src kinase activity in NIH-EGFR/ALK cells following EGF stimulation. Quiescent NIH-EGFR/ALK cells were either mock-treated or treated with 100 ng/mL EGF for the indicated time at 37°C. Cell lysates were immunoprecipitated with an anti-p60src antibody. (A) An aliquot from each immunoprecipitate was directly analyzed by immunoblotting to evaluate p60src content. (B) The remainder of each immunoprecipitate was subjected to in vitro kinase assay in the presence of [γ-32P] ATP and acid-denaturated enolase. Samples were then analyzed by SDS-PAGE and autoradiography. (C) The 32P content of bands corresponding to enolase shown in panel B was quantified by densitometric scanning of the autoradiograms and results are expressed as percent of control (signal obtained from medium-treated cells).

Close Modal

or Create an Account

Close Modal
Close Modal